Genome-wide association study of intraocular pressure identifies the GLCCI1/ICA1 region as a glaucoma susceptibility locus

Human Molecular Genetics

Volumn 22, Issue 22, 2013, Pages 4653-4660

  Strange, Amy ^a   Bellenguez, Céline ^a   Sim, Xueling ^b   Luben, Robert ^c   Hysi, Pirro G ^d   Ramdas, Wishal D ^e   van Koolwijk, Leonieke M E ^f   Freeman, Colin ^a   Pirinen, Matti ^a   Su, Zhan ^a   Band, Gavin ^a   Pearson, Richard ^a   Vukcevic, Damjan ^a   Langford, Cordelia ^g   Deloukas, Panos ^g   Hunt, Sarah ^g   Gray, Emma ^g   Dronov, Serge ^g   Potter, Simon C ^g   Tashakkori Ghanbaria, Avazeh ^g   Edkins, Sarah ^g   Bumpstead, Suzannah J ^g   Blackwell, Jenefer M ^h,i   Bramon, Elvira ^j,k   Brown, Matthew A ^l   Casas, Juan P ^k,m   Corvin, Aiden ⁿ   Duncanson, Audrey ^o   Jankowski, Janusz A Z ^p,q,r   Markus, Hugh S ^s   Mathew, Christopher G ^t   Palmer, Colin N A ^u   Plomin, Robert ^v   Rautanen, Anna ^a   Sawcer, Stephen J ^w   Trembath, Richard C ^t   Wood, Nicholas W ^x   Barroso, Ines ^g   Leena Peltonen, Leena Peltonen ^g   Healey, Paul ^y   McGuffin, Peter ^v   Topouzis, Fotis ^z   Klaver, Caroline C W ^e   van Duijn, Cornelia M ^e   Mackey, David A ^aa   Young, Terri L ^ab   Hammond, Christopher J ^d   Khaw, Kay Tee ^c   Wareham, Nick ^ac   Wang, Jie Jin ^y,ad   Wong, Tien Y ^b   Foster, Paul J ^ae   Mitchell, Paul ^y   Spencer, Chris C A ^a   Donnelly, Peter ^a,q   Viswanathan, Ananth C ^ae   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f ROTTERDAM EYE HOSPITAL   (Netherlands)

^g WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l UNIVERSITY OF QUEENSLAND   (Australia)

^m LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁿ TRINITY COLLEGE DUBLIN   (Ireland)

^o WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^p QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^q UNIVERSITY OF OXFORD   (United Kingdom)

^r LEICESTER ROYAL INFIRMARY   (United Kingdom)

^s ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^t GUY S HOSPITAL   (United Kingdom)

^u UNIVERSITY OF DUNDEE   (United Kingdom)

^v KING'S COLLEGE LONDON   (United Kingdom)

^w UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^x UNIVERSITY COLLEGE LONDON   (United Kingdom)

^y UNIVERSITY OF SYDNEY   (Australia)

^z ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^aa UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^ab DUKE UNIVERSITY MEDICAL CENTER   (United States)

^ac MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^ad UNIVERSITY OF MELBOURNE   (Australia)

^ae UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLCCI1 PROTEIN; ICA1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; AUSTRALIA; COHORT ANALYSIS; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; AUSTRALIA; AUTOANTIGENS; CHROMOSOMES, HUMAN, PAIR 7; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; QUANTITATIVE TRAIT LOCI; RECEPTORS, GLUCOCORTICOID; RISK FACTORS;

EID: 84887010281     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt293     Document Type: Article

References (70)

1. Resnikoff, S., Pascolini, D., Etya'ale, D., Kocur, I., Pararajasegaram, R., Pokharel, G.P. and Mariotti, S.P. (2004) Global data on visual impairment in the year 2002. Bull. World Health Organ., 82, 844-851.
2. Quigley, H.A. (2011) Glaucoma. Lancet, 377, 1367-1377.
3. Haymes, S.A., Leblanc, R.P., Nicolela, M.T., Chiasson, L.A. and Chauhan, B.C. (2007) Risk of falls and motor vehicle collisions in glaucoma. Invest. Ophthalmol. Vis. Sci., 48, 1149-1155.
4. White, S.C., Atchison, K.A., Gornbein, J.A., Nattiv, A., Paganini-Hill, A. and Service, S.K. (2006) Risk factors for fractures in older men and women: the Leisure World Cohort Study. Gend. Med., 3, 110-123.
5. McGwin,G. Jr, Xie, A., Mays, A., Joiner, W., DeCarlo, D.K., Hall, T.A. and Owsley, C. (2005) Visual field defects and the risk of motor vehicle collisions among patients with glaucoma. Invest. Ophthalmol. Vis. Sci., 46, 4437-4441.
6. Quigley, H.A. and Broman, A.T. (2006) The number of people with glaucoma worldwide in 2010 and 2020. Brit. J. Ophthalmol., 90, 262-267.
7. Leske, M.C. (1983) The epidemiology of open-angle glaucoma a review. Am. J. Epidemiol., 118, 166-191.
8. Sommer, A., Katz, J., Quigley, H.A., Miller, N.R., Robin, A.L., Richter, R.C. and Witt, K.A. (1991) Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch. Ophthalmol., 109, 77-83.
9. Smith, R.J. (1986) The Lang lecture 1986. The enigma of primary open-angle glaucoma. Trans. Ophthalmol. Soc. UK, 105, 618-633.
10. Migdal, C. and Hitchings, R. (1986) Control of chronic simple glaucoma with primary medical, surgical and laser treatment. Trans. Ophthalmol. Soc. UK, 105, 653-656.
11. Jay, J.L. and Murray, S.B. (1988) Early trabeculectomy versus conventional management in primary open angle glaucoma. Br. J. Ophthalmol., 72, 881-889.
12. Sommer, A. (1989) Intraocular pressure and glaucoma. Am. J. Ophthalmol., 107, 186-188.
13. Vogel, R., Crick, R.P., Newson, R.B., Shipley, M., Blackmore, H. and Bulpitt, C.J. (1990) Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br. J. Ophthalmol., 74, 3-6.
14. Mao, L.K., Stewart, W.C. and Shields, M.B. (1991) Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am. J. Ophthalmol., 111, 51-55.
15. Weber, J., Koll, W. and Krieglstein, G.K. (1993) Intraocular pressure and visual field decay in chronic glaucoma. Ger. J. Ophthalmol., 2, 165-169.
16. Airaksinen, P.J., Tuulonen, A. and Alanko, H.I. (1992) Rate and pattern of neuroretinal rim area decrease in ocular hypertension and glaucoma. Arch. Ophthalmol., 110, 206-210.
17. Cartwright, M.J. and Anderson, D.R. (1988) Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma). Arch. Ophthalmol., 106, 898-900.
18. Kass, M.A., Heuer, D.K., Higginbotham, E.J., Johnson, C.A., Keltner, J.L., Miller, J.P., Parrish, R.K. II, Wilson, M.R. and Gordon, M.O. (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol., 120, 701-713. Discussion 829-730.
19. Heijl, A., Leske, M.C., Bengtsson, B., Hyman, L. and Hussein, M. (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch. Ophthalmol., 120, 1268-1279.
20. AGIS Investigators. (2000) The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol., 130, 429-440.
21. Collaborative Normal-Tension Glaucoma Study Group. (1998) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am. J. Ophthalmol., 126, 498-505.
22. Charlesworth, J., Kramer, P.L., Dyer, T., Diego, V., Samples, J.R., Craig, J.E., Mackey, D.A., Hewitt, A.W., Blangero, J. and Wirtz, M.K. (2010) The path to open-angle glaucoma gene discovery: endophenotypic status of intraocular pressure, cup-to-disc ratio, and central corneal thickness. Invest. Ophthalmol. Vis. Sci., 51, 3509-3514.
23. Gemenetzi, M., Yang, Y. and Lotery, A.J. (2012) Current concepts on primary open-angle glaucoma genetics: a contribution to disease pathophysiology and future treatment. Eye, 26, 355-369.
24. Carbonaro, F., Andrew, T., Mackey, D.A., Spector, T.D. andHammond, C.J. (2008) Heritability of intraocular pressure: a classical twin study. Br. J. Ophthalmol., 92, 1125-1128.
25. Levene, R.Z., Workman, P.L., Broder, S.W. and Hirschhorn, K. (1970) Heritability of ocular pressure in normal and suspect ranges. Arch. Ophthalmol., 84, 730-734.
26. Klein, B.E., Klein, R. and Lee, K.E. (2004) Heritability of risk factors for primary open-angle glaucoma: the Beaver Dam Eye Study. Invest. Ophthalmol. Vis. Sci., 45, 59-62.
27. Chang, T.C., Congdon, N.G., Wojciechowski, R., Munoz, B., Gilbert, D., Chen, P., Friedman, D.S. and West, S.K. (2005) Determinants and heritability of intraocular pressure and cup-to-disc ratio in a defined older population. Ophthalmology, 112, 1186-1191.
28. van Koolwijk, L.M., Despriet, D.D., van Duijn, C.M., Pardo Cortes, L.M., Vingerling, J.R., Aulchenko, Y.S., Oostra, B.A., Klaver, C.C. and Lemij, H.G. (2007) Genetic contributions to glaucoma: heritability of intraocular pressure, retinal nerve fiber layer thickness, and optic disc morphology. Invest. Ophthalmol. Vis. Sci., 48, 3669-3676.
29. Charlesworth, J.C., Dyer, T.D., Stankovich, J.M., Blangero, J., Mackey, D.A., Craig, J.E., Green, C.M., Foote, S.J., Baird, P.N. and Sale, M.M. (2005) Linkage to 10q22 for maximum intraocular pressure and 1p32 for maximum cup-to-disc ratio in an extended primary open-angle glaucoma pedigree. Invest. Ophthalmol. Vis. Sci., 46, 3723-3729.
30. Rotimi, C.N., Chen, G., Adeyemo, A.A., Jones, L.S., Agyenim-Boateng, K., Eghan, B.A. Jr, Zhou, J., Doumatey, A., Lashley, K., Huang, H. et al. (2006) Genomewide scan and fine mapping of quantitative trait loci for intraocular pressure on 5q and 14q in West Africans. Invest. Ophthalmol. Vis. Sci., 47, 3262-3267.
31. van Koolwijk, L.M., Ramdas, W.D., Ikram, M.K., Jansonius, N.M., Pasutto, F., Hysi, P.G., Macgregor, S., Janssen, S.F., Hewitt, A.W., Viswanathan, A.C. et al. (2012)Commongenetic determinants of intraocular pressure and primary open-angle glaucoma. PLoS Genet., 8, e1002611.
32. Burdon, K.P., Macgregor, S., Hewitt, A.W., Sharma, S., Chidlow, G., Mills, R.A., Danoy, P., Casson, R., Viswanathan, A.C., Liu, J.Z. et al. (2011) Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat. Genet., 43, 574-578.
33. Howie, B.N., Donnelly, P. and Marchini, J. (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet., 5, e1000529.
34. [1000] Genomes Project Consortium. (2010) A map of human genome variation from population-scale sequencing. Nature, 467, 1061-1073.
35. Marchini, J. and Howie, B. (2010) Genotype imputation for genome-wide association studies. Nat. Rev. Genet., 11, 499-511.
36. Cortes, A. and Brown, M.A. (2011) Promise and pitfalls of the immunochip. Arthritis Res. Ther., 13, 101.
37. Meguro, A., Inoko, H., Ota, M., Mizuki, N. and Bahram, S. (2010) Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology, 117, 1331-1338.
38. Thorleifsson, G., Magnusson, K.P., Sulem, P., Walters, G.B., Gudbjartsson, D.F., Stefansson, H., Jonsson, T., Jonasdottir, A., Stefansdottir, G., Masson, G. et al. (2007) Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science, 317, 1397-1400.
39. Thorleifsson, G., Walters, G.B., Hewitt, A.W., Masson, G., Helgason, A., DeWan, A., Sigurdsson, A., Jonasdottir, A., Gudjonsson, S.A., Magnusson, K.P. et al. (2010) Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat. Genet., 42, 906-909.
40. Spector, T.D. and Williams, F.M. (2006) The UK Adult Twin Registry (TwinsUK). Twin Res. Hum. Genet., 9, 899-906.
41. Marchini, J., Howie, B., Myers, S., McVean, G. and Donnelly, P. (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet., 39, 906-913.
42. Buffa, L., Fuchs, E., Pietropaolo, M., Barr, F. and Solimena, M. (2008) ICA69Is a novelRab2effector regulating ER-golgi trafficking in insulinoma cells. Eur. J. Cell Biol., 87, 197-209.
43. Gaedigk, R., Duncan, A.M., Miyazaki, I., Robinson, B.H. and Dosch, H.M. (1994) ICA1 Encoding p69, a protein linked to the development of type 1 diabetes, maps to human chromosome 7p22. Cytogenet. Cell Genet., 66, 274-276.
44. Winer, S., Astsaturov, I., Cheung, R., Tsui, H., Song, A., Gaedigk, R., Winer, D., Sampson, A., McKerlie, C., Bookman, A. et al. (2002) Primary Sjogren's syndrome and deficiency of ICA69. Lancet, 360, 1063-1069.
45. Chapman, M.S., Qu, N., Pascoe, S., Chen, W.X., Apostol, C., Gordon, D. and Miesfeld, R.L. (1995) Isolation of differentially expressed sequence tags from steroid-responsive cells using mRNA differential display. Mol. Cell Endocrinol., 108, R1-R7.
46. Tantisira, K.G., Lasky-Su, J., Harada, M., Murphy, A., Litonjua, A.A., Himes, B.E., Lange, C., Lazarus, R., Sylvia, J., Klanderman, B. et al. (2011) Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N. Engl. J. Med., 365, 1173-1183.
47. Becker, B. (1965) Intraocular pressure response to topical corticosteroids. Invest. Ophthalmol., 4, 198-205.
48. Davies, T.G. (1968) Tonographic survey of the close relatives of patients with chronic simple glaucoma. Br. J. Ophthalmol., 52, 32-39.
49. Mitchell, P., Cumming, R.G. and Mackey, D.A. (1999) Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology, 106, 2301-2306.
50. Ray, S., Mehra, K.S., Misra, S. and Singh, R. (1977) Plasma cortisol in glaucoma. Ann. Ophthalmol., 9, 1151-1154.
51. Meredig, W.E., Pulhorn, G., Jentzen, F. and Hartmann, F. (1980) Plasmacortisol level in patients suffering from glaucoma. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 213, 215-218.
52. Rozsival, P., Hampl, R., Obenberger, J., Starka, L. and Rehak, S. (1981) Aqueous humour and plasma cortisol levels in glaucoma and cataract patients. Curr. Eye Res., 1, 391-396.
53. McCarty, G.R. and Schwartz, B. (1991) Increased plasma noncortisol glucocorticoid activity in open-angle glaucoma. Invest. Ophthalmol. Vis. Sci., 32, 1600-1608.
54. Schwartz, B., McCarty, G. and Rosner, B. (1987) Increased plasma free cortisol in ocular hypertension and open angle glaucoma. Arch. Ophthalmol., 105, 1060-1065.
55. Stone, E.M., Fingert, J.H., Alward, W.L., Nguyen, T.D., Polansky, J.R., Sunden, S.L., Nishimura, D., Clark, A.F., Nystuen, A., Nichols, B.E. et al. (1997) Identification of a gene that causes primary open angle glaucoma. Science, 275, 668-670.
56. Polansky, J.R., Fauss, D.J., Chen, P., Chen, H., Lutjen-Drecoll, E., Johnson, D., Kurtz, R.M., Ma, Z.D., Bloom, E. and Nguyen, T.D. (1997) Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica, 211, 126-139.
57. Jiang, X., Varma, R., Wu, S., Torres, M., Azen, S.P., Francis, B.A., Chopra, V. and Nguyen, B.B. and Los Angeles Latino Eye Study, G. (2012) Baseline risk factors that predict the development of open-angle glaucoma in a population: the Los Angeles Latino Eye Study. Ophthalmology, 119, 2245-2253.
58. Mitchell, P., Smith, W., Attebo, K. and Healey, P.R. (1996) Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology, 103, 1661-1669.
59. Leske, M.C., Heijl, A., Hyman, L., Bengtsson, B., Dong, L., Yang, Z. and Group, E. (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology, 114, 1965-1972.
60. Mitchell, P., Smith, W., Attebo, K. and Wang, J.J. (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology, 102, 1450-1460.
61. Sommer, A., Tielsch, J.M., Katz, J., Quigley, H.A., Gottsch, J.D., Javitt, J. and Singh, K. (1991) Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch. Ophthalmol., 109, 1090-1095.
62. Klein, B.E., Klein, R., Sponsel, W.E., Franke, T., Cantor, L.B., Martone, J. and Menage, M.J. (1992) Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology, 99, 1499-1504.
63. Dielemans, I., Vingerling, J.R., Hofman, A., Grobbee, D.E. and de Jong, P.T. (1994) Reliability of intraocular pressure measurement with the Goldmann applanation tonometer in epidemiological studies. Graefes Arch. Klin. Exp. Ophthalmol., 232, 141-144.
64. Riboli, E. (1992) Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann. Oncol., 3, 783-791.
65. Day, N., Oakes, S., Luben, R., Khaw, K.T., Bingham, S., Welch, A. and Wareham, N. (1999) EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br. J. Cancer, 80(Suppl. 1), 95-103.
66. Conrad, D.F., Pinto, D., Redon, R., Feuk, L., Gokcumen, O., Zhang, Y., Aerts, J., Andrews, T.D., Barnes, C., Campbell, P. et al. (2009) Origins and functional impact of copy number variation in the human genome. Nature, 464, 704-712.
67. Bellenguez, C., Strange, A., Freeman, C., Donnelly, P. and Spencer, C.C. (2011) A robust clustering algorithm for identifying problematic samples in genome-wide association studies. Bioinformatics, 28, 134-135.
68. Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C.C., Patsopoulos, N.A., Moutsianas, L., Dilthey, A., Su, Z., Freeman, C., Hunt, S.E. et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature, 476, 214-219.
69. Devaux, P.F. (2000) Is lipid translocation involved during endo- and exocytosis? Biochimie, 82, 497-509.
70. Ory, S., Ceridono, M., Momboisse, F., Houy, S., Chasserot-Golaz, S., Heintz, D., Calco, D., Haeberlé, A-M., Espinoza, F.A., Sims, P.J. et al. (2013) Phospholipid scramblase-1-induced lipid reorganization regulates compensatory endocytosis in neuroendocrine cells. J. Neurosci., 33, 3545-3556.